Cargando…
CSNK2 in cancer: pathophysiology and translational applications
Protein kinase CSNK2 (CK2) is a pleiotropic serine/threonine kinase frequently dysregulated in solid and hematologic malignancies. To consolidate a wide range of biological and clinically oriented data from this unique kinase in cancer, this systematic review summarises existing knowledge from in vi...
Autores principales: | Strum, Scott W., Gyenis, Laszlo, Litchfield, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980014/ https://www.ncbi.nlm.nih.gov/pubmed/34773100 http://dx.doi.org/10.1038/s41416-021-01616-2 |
Ejemplares similares
-
Chemical Genetic Validation of CSNK2 Substrates Using an Inhibitor-Resistant Mutant in Combination with Triple SILAC Quantitative Phosphoproteomics
por: Gyenis, Laszlo, et al.
Publicado: (2022) -
Unbiased Functional Proteomics Strategy for Protein Kinase Inhibitor Validation and Identification of bona fide Protein Kinase Substrates: Application to Identification of EEF1D as a Substrate for CK2
por: Gyenis, Laszlo, et al.
Publicado: (2011) -
Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases
por: Unni, Prasida, et al.
Publicado: (2022) -
Targeting Csnk1a1 in leukemia
por: Stegmaier, Kimberly
Publicado: (2014) -
Pannexin 2 is expressed in murine skin and promotes UVB-induced apoptosis of keratinocytes
por: Sanchez-Pupo, Rafael E., et al.
Publicado: (2022)